CIDRAP newsletters options
A Sri Lankan analysis of global COVID-19 intervention measures showed that increased testing had the greatest impact on transmission: a 10-fold increase in the ratio of tests to new cases (TCR) reduced a country's average transmission by 9%. The study authors suggest that intense testing combined with isolation may be the most effective and least costly strategy for controlling COVID-19.
An outbreak of carbapenem-resistant Acinetobacter baumannii happened after some control steps were altered.
The CDC advises 10 days of quarantine with no symptoms and 7 days if no symptoms and a negative test.
The UK becomes the first country in the world to approve a COVID-19 vaccine for emergency use.
A New England Journal of Medicine study yesterday of cancer patients with COVID-19 demonstrated viral RNA shedding for up to 78 days and live virus for up to 61 days, suggesting extended infectiousness in patients whose immune system is suppressed.
Telephone consultations could be the reason why antibiotic prescribing at general practices in the United Kingdom was higher than expected during the first COVID-19 lockdown, researchers with the University of Nottingham reported yesterday in the Lancet Infectious Diseases.
The pandemic has pushed the number of people needing humanitarian assistance up 40%, a record high.
The number of Americans currently hospitalized for COVID-19 reaches 96,039, up from 93,219 the day before.
The report calls for increased transparency on vaccine and treatment development and meeting states' needs for scarce medical supplies.
The experts also raised the possibility that, for the next phase, essential workers could be placed ahead of seniors and those with underlying conditions as a way to prioritize people of color, who have higher risk.
"World Malaria Report 2020" notes 229 million cases and 409,000 deaths last year, with young kids especially hit hard.
CARB-X today announced two new funding awards for German scientists working on therapies for difficult-to-treat bacterial infections.
A study in Clinical Infectious Diseases yesterday found that 1% of US blood donations late last year and in early 2020 contained SARS-CoV-2 antibodies, suggesting that the virus was present in the United States earlier than previously thought.
SARS-CoV-2, the virus that causes COVID-19, was first recognized in Wuhan, China, in December 2019, and the initial US case was identified on Jan 19.
FDA experts will likely meet Dec 17 to review safety and efficacy data.
Shortages are supplemented but not fixed with traveling nurses, other steps.
The number of Americans hospitalized with COVID-19 continues a record-breaking rise.
Black children had more than triple the rate of multisystem inflammatory syndrome than white kids did.
A group of clinicians and researchers with expertise in pediatric healthcare-associated infections (HAIs) and antimicrobial stewardship has developed a list of high-priority research topics for improving health outcomes in children.
A small German autopsy study of COVID-19 victims in Nature Neuroscience today demonstrates the presence of SARS-CoV-2—the virus that causes COVID-19—in nasal structures and the brain, suggesting that the virus crosses into the central nervous system (CNS) via nasal surfaces that contain nerve endings for smell.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Originally published by CIDRAP News Nov 23
